Novel crystalline forms of {2-(1-(3,5-bis-trifluoromethylbenzyl)-5-p yridin4-yl-1H-(1,2,3)triazol-4-yl)-pyridin-3-yl}-( 2-chlorophenyl)-methanone
Details for Australian Patent Application No. 2004285855 (hide)
International Classifications
Event Publications
13 April 2006 PCT application entered the National Phase
PCT publication WO2005/042515 Priority application(s): WO2005/042515
23 December 2010 Application Accepted
Published as AU-B-2004285855
21 April 2011 Standard Patent Sealed
28 April 2011 Corrigenda
Applications Accepted - Name Index Under the name Eli Lilly and Company, Application No. 2004285855, under INID (54) correct the title to read Novel crystalline forms of {2-[1-(3,5-bis-trifluoromethylbenzyl) -5 - pyridin4-yl-1H-[1,2,3]triazol-4-yl]-pyridin-3-yl}-(2-chlorophenyl)-methanone
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
2004285859-Novel zeolite composite, method for making and catalytic application thereof
2004285852-Process for preparing functional groupcontaining olefinic compounds
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
- Editable Word format reports
- For IP Professionals
- Multiuser